SLN.L - Silence Therapeutics plc

LSE - LSE Delayed price. Currency in GBp
Currency in GBp

Valuation measures

Market cap (intra-day) 5336.1M
Enterprise value 3268.41M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)1,091.86
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-13.47

Trading information

Stock price history

Beta (5Y monthly) 1.76
52-week change 3693.95%
S&P500 52-week change 36.98%
52-week high 3613.80
52-week low 340.00
50-day moving average 3389.14
200-day moving average 3336.66

Share statistics

Avg vol (3-month) 3238.18k
Avg vol (10-day) 394.21k
Shares outstanding 578.37M
Float 32.21M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 330 Apr 2013

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)30 Jun 2019


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-32.85%
Return on equity (ttm)-50.43%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-9.74M
EBITDA -19.92M
Net income avi to common (ttm)-17.93M
Diluted EPS (ttm)-25.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.51M
Total cash per share (mrq)0.23
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.26
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-18.24M
Levered free cash flow (ttm)-13.03M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more